SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 97 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $489,000 | -22.0% | 281,230 | -0.0% | 0.02% | -9.5% |
| Q2 2015 | $627,000 | +19.2% | 281,280 | +3.7% | 0.02% | +16.7% |
| Q1 2015 | $526,000 | -32.0% | 271,280 | -7.1% | 0.02% | -33.3% |
| Q4 2014 | $773,000 | -20.0% | 291,880 | -9.0% | 0.03% | -25.0% |
| Q3 2014 | $966,000 | – | 320,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
| Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
| CAXTON CORP | 57,000 | $99,000 | 0.13% |
| Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
| TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
| Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
| LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
| Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |